Since TYK2 had a positive effect on ESCC proliferation, we attempted to identify an inhibitor of TYK2; hence we used an in-silico docking assay to screen compounds from natural compound library. This evidence concerns the gene TYK2 and esophageal squamous cell carcinoma.